Author

Rachel Whitehead

Mayo Clinic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Paula V. SchiapparelliiD· 2 shared Steven S. RosenfeldiD· 2 shared Aleeshba N. BasiliD· 1 shared Alfredo Quinones Hinojosa· 1 shared Alfredo Quiñones‐HinojosaiD· 1 shared Asha Nair· 1 shared Brianna Tapia-Dierking· 1 shared Claudia PalenaiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Paula V. SchiapparelliORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Intracranial Targeting of Cholesterol Processing Reveals a Therapeutic Vulnerability that Reprograms Glioblastoma and Promotes Antitumor Immunity

María José Ulloa-Navas, Rachel Whitehead, Vanessa K. Jones, Loizos Michaelides, Mieu Brooks, Aleeshba N. Basil, Raquel Morales‐Gallel, Cristina Gomez-Palmero, Graciela Abril Reynaga-Macias, Jesus Emiliano Sanchez-Garavito, Brianna Tapia-Dierking, Asha Nair, Juan Pablo Navarro Garcia de Llano, Paula V. Schiapparelli, Ian Dryden, , Alfredo Quiñones‐Hinojosa

This study identifies cholesterol dependency as a therapeutic target in glioblastoma, showing that combined treatment with clemastine and bexarotene induces metabolic collapse and enhances antitumor immunity.

bioRxiv · Aug 19, 2026 · PreprintCancer Biology

Inhibition of Yes-Associated Protein (YAP) with Verteporfin Enhances Radiosensitivity in Chordoma by Inducing G2M Arrest and Inhibiting the DNA Damage Response

Oluwaseun Oluwadara Akinduro, Paola Suarez Meade, Paula V. Schiapparelli, Rachel Whitehead, Stephany Yi Tzeng, Steven S. Rosenfeld, Sungjune Kim, Claudia Palena, Ziya L. Gokaslan, Jordan J. Green, Alfredo Quinones Hinojosa

This study shows that YAP inhibition with verteporfin increases radiosensitivity in chordoma by blocking DNA repair and causing G2M arrest.

bioRxiv · Nov 3, 2024 · PreprintCancer Biology